about
Psoriatic arthritis: an evolving matter.Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis.cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.Emerging oral drugs for psoriasis.Emerging drugs for psoriatic arthritis.Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Apremilast for the treatment of psoriatic arthritis.
@en
type
label
Apremilast for the treatment of psoriatic arthritis.
@en
prefLabel
Apremilast for the treatment of psoriatic arthritis.
@en
P2093
P2860
P1476
Apremilast for the treatment of psoriatic arthritis.
@en
P2093
Alice B Gottlieb
Sowmya Varada
Suzanne J Tintle
P2860
P304
P356
10.1586/17512433.2014.904200
P407
P577
2014-04-04T00:00:00Z